Article Versions Notes

Peugnet V, Chwastyniak M, Mulder P, Lancel S, Bultot L, Fourny N, Renguet E, Bugger H, Beseme O, Loyens A, et al. Mitochondrial-Targeted Therapies Require Mitophagy to Prevent Oxidative Stress Induced by SOD2 Inactivation in Hypertrophied Cardiomyocytes. Antioxidants. 2022; 11(4):723. https://doi.org/10.3390/antiox11040723

Peugnet, Victoriane, Maggy Chwastyniak, Paul Mulder, Steve Lancel, Laurent Bultot, Natacha Fourny, Edith Renguet, Heiko Bugger, Olivia Beseme, Anne Loyens, and et al. 2022. "Mitochondrial-Targeted Therapies Require Mitophagy to Prevent Oxidative Stress Induced by SOD2 Inactivation in Hypertrophied Cardiomyocytes" Antioxidants 11, no. 4: 723. https://doi.org/10.3390/antiox11040723

Peugnet, V., Chwastyniak, M., Mulder, P., Lancel, S., Bultot, L., Fourny, N., Renguet, E., Bugger, H., Beseme, O., Loyens, A., Heyse, W., Richard, V., Amouyel, P., Bertrand, L., Pinet, F., & Dubois-Deruy, E. (2022). Mitochondrial-Targeted Therapies Require Mitophagy to Prevent Oxidative Stress Induced by SOD2 Inactivation in Hypertrophied Cardiomyocytes. Antioxidants, 11(4), 723. https://doi.org/10.3390/antiox11040723